BIOMARIN PHARMACEUTICAL COM STK USD0.001 earnings per share and revenue

0HNC earnings per share for the last quarter are 0.55 USD whereas the estimation was 0.53 USD which accounts for 3.59% surprise. Company revenue for the same period amounts to 745.74 M USD despite the estimated figure of 703.43 M USD. Estimated earnings per share for the next quarter are 0.55 USD, and revenue is expected to reach 713.24 M USD. Also watch annual changes over time to get a bigger picture of 0HNC earnings per share and revenue dynamics.